Animal health professionals
On this page, you will find information on the Agency’s activities, including news and events, that are most relevant to Animal health professionals and users of veterinary medicines such as pet owners. You can contribute to the Agency’s work by responding to public consultations. Learn more about the European Medicines Agency's Committee for Medicinal Products for Veterinary Use (CVMP) and its role regarding medicines for veterinary use.
Featured information
-
List item
Coronavirus disease (COVID-19): Monitoring the impact on medicine supply chains
The European medicines regulatory network is closely monitoring the potential impact of the COVID-19 pandemic on the veterinary medicine supply chain in the EU.
-
List item
Suspected side effect reports of veterinary medicines
EMA is making suspected side effect reports of veterinary medicines authorised in the EU publicly accessible in the European database for suspected adverse drug reaction reports. The reports come from Eudravigilance Veterinary (EVVet), a database for processing pharmacovigilance reports of authorised veterinary medicines.
-
List item
Responsible use of antibiotics: What’s your role?
To mark European Antibiotic Awareness Day on 18 November 2019, EMA has launched a social media campaign to highlight the importance of using antibiotics responsibly. The campaign includes visuals describing what ‘responsible use’ means for veterinarians.
-
List item
Preventing Brexit-related medicine shortages
EMA has published a questions-and-answers document to address potential questions from stakeholders on the supply of medicines in the EU after Brexit and what the Agency, the European Commission and national competent authorities in the Member States are doing to prevent potential medicine supply shortages due to Brexit.
-
List item
Healthy animals, healthy people
EMA’s leaflet shows how the Agency promotes safe and effective veterinary therapies. The leaflet highlights the connection between animals and people’s health on topics like antimicrobial resistance or consumers’ safety.
-
List item
New technologies, new types of medicines and therapies
EMA’s Ad Hoc Expert Group on Veterinary Novel Therapies (ADVENT) provides guidance on development and authorisation of novel therapies. The group published, for the first time, specific guidance on monoclonal antibodies in December 2017.
-
List item
Publications
in 31 European countries in 2017
